Chicago Partners Investment Group’s Janux Therapeutics JANX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-4,621
| Closed | -$235K | – | 965 |
|
|
2024
Q4 | $235K | Sell |
4,621
-630
| -12% | -$32K | 0.01% | 753 |
|
|
2024
Q3 | $272K | Buy |
+5,251
| New | +$272K | 0.01% | 651 |
|
|
2024
Q2 | – | Sell |
-8,464
| Closed | -$421K | – | 756 |
|
|
2024
Q1 | $421K | Buy |
+8,464
| New | +$421K | 0.02% | 495 |
|
|
2022
Q4 | – | Sell |
-10,621
| Closed | -$181K | – | 651 |
|
|
2022
Q3 | $181K | Buy |
+10,621
| New | +$181K | 0.01% | 543 |
|
|
2022
Q1 | – | Sell |
-11,380
| Closed | -$188K | – | 589 |
|
|
2021
Q4 | $188K | Buy |
11,380
+1,922
| +20% | +$31.8K | 0.01% | 533 |
|
|
2021
Q3 | $235K | Buy |
+9,458
| New | +$235K | 0.02% | 503 |
|